APA (7th ed.) Citation

Gao, X., Li, J., Xu, S., Li, X., Wang, X., Li, Y., . . . Zeng, Q. (2023). Oral nicotinamide mononucleotide (NMN) to treat chronic insomnia: Protocol for the multicenter, randomized, double-blinded, placebo-controlled trial. Current controlled trials in cardiovascular medicine, 24(1), 340-12. https://doi.org/10.1186/s13063-023-07351-8

Chicago Style (17th ed.) Citation

Gao, Xiangyang, Junhua Li, Sanping Xu, Xueying Li, Xicheng Wang, Yongli Li, Yan Huang, Shaohui Liu, and Qiang Zeng. "Oral Nicotinamide Mononucleotide (NMN) to Treat Chronic Insomnia: Protocol for the Multicenter, Randomized, Double-blinded, Placebo-controlled Trial." Current Controlled Trials in Cardiovascular Medicine 24, no. 1 (2023): 340-12. https://doi.org/10.1186/s13063-023-07351-8.

MLA (9th ed.) Citation

Gao, Xiangyang, et al. "Oral Nicotinamide Mononucleotide (NMN) to Treat Chronic Insomnia: Protocol for the Multicenter, Randomized, Double-blinded, Placebo-controlled Trial." Current Controlled Trials in Cardiovascular Medicine, vol. 24, no. 1, 2023, pp. 340-12, https://doi.org/10.1186/s13063-023-07351-8.